Cargando…

Ferroptosis in Cardiovascular Diseases: Current Status, Challenges, and Future Perspectives

Cardiovascular diseases (CVDs) are still a major cause of global mortality and disability, seriously affecting people’s lives. Due to the severity and complexity of these diseases, it is important to find new regulatory mechanisms to treat CVDs. Ferroptosis is a new kind of regulatory cell death cur...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yi, Lu, Chanjun, Hu, Ke, Cai, Chuanqi, Wang, Weici
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945958/
https://www.ncbi.nlm.nih.gov/pubmed/35327582
http://dx.doi.org/10.3390/biom12030390
_version_ 1784674078625366016
author Guo, Yi
Lu, Chanjun
Hu, Ke
Cai, Chuanqi
Wang, Weici
author_facet Guo, Yi
Lu, Chanjun
Hu, Ke
Cai, Chuanqi
Wang, Weici
author_sort Guo, Yi
collection PubMed
description Cardiovascular diseases (CVDs) are still a major cause of global mortality and disability, seriously affecting people’s lives. Due to the severity and complexity of these diseases, it is important to find new regulatory mechanisms to treat CVDs. Ferroptosis is a new kind of regulatory cell death currently being investigated. Increasing evidence showed that ferroptosis plays an important role in CVDs, such as in ischemia/reperfusion injury, heart failure, cardiomyopathy, and atherosclerosis. Protecting against CVDs by targeting ferroptosis is a promising approach; therefore, in this review, we summarized the latest regulatory mechanism of ferroptosis and the current studies related to each CVD, followed by critical perspectives on the ferroptotic treatment of CVDs and the future direction of this intriguing biology.
format Online
Article
Text
id pubmed-8945958
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89459582022-03-25 Ferroptosis in Cardiovascular Diseases: Current Status, Challenges, and Future Perspectives Guo, Yi Lu, Chanjun Hu, Ke Cai, Chuanqi Wang, Weici Biomolecules Review Cardiovascular diseases (CVDs) are still a major cause of global mortality and disability, seriously affecting people’s lives. Due to the severity and complexity of these diseases, it is important to find new regulatory mechanisms to treat CVDs. Ferroptosis is a new kind of regulatory cell death currently being investigated. Increasing evidence showed that ferroptosis plays an important role in CVDs, such as in ischemia/reperfusion injury, heart failure, cardiomyopathy, and atherosclerosis. Protecting against CVDs by targeting ferroptosis is a promising approach; therefore, in this review, we summarized the latest regulatory mechanism of ferroptosis and the current studies related to each CVD, followed by critical perspectives on the ferroptotic treatment of CVDs and the future direction of this intriguing biology. MDPI 2022-03-02 /pmc/articles/PMC8945958/ /pubmed/35327582 http://dx.doi.org/10.3390/biom12030390 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Guo, Yi
Lu, Chanjun
Hu, Ke
Cai, Chuanqi
Wang, Weici
Ferroptosis in Cardiovascular Diseases: Current Status, Challenges, and Future Perspectives
title Ferroptosis in Cardiovascular Diseases: Current Status, Challenges, and Future Perspectives
title_full Ferroptosis in Cardiovascular Diseases: Current Status, Challenges, and Future Perspectives
title_fullStr Ferroptosis in Cardiovascular Diseases: Current Status, Challenges, and Future Perspectives
title_full_unstemmed Ferroptosis in Cardiovascular Diseases: Current Status, Challenges, and Future Perspectives
title_short Ferroptosis in Cardiovascular Diseases: Current Status, Challenges, and Future Perspectives
title_sort ferroptosis in cardiovascular diseases: current status, challenges, and future perspectives
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945958/
https://www.ncbi.nlm.nih.gov/pubmed/35327582
http://dx.doi.org/10.3390/biom12030390
work_keys_str_mv AT guoyi ferroptosisincardiovasculardiseasescurrentstatuschallengesandfutureperspectives
AT luchanjun ferroptosisincardiovasculardiseasescurrentstatuschallengesandfutureperspectives
AT huke ferroptosisincardiovasculardiseasescurrentstatuschallengesandfutureperspectives
AT caichuanqi ferroptosisincardiovasculardiseasescurrentstatuschallengesandfutureperspectives
AT wangweici ferroptosisincardiovasculardiseasescurrentstatuschallengesandfutureperspectives